US Stock MarketDetailed Quotes
ELV Elevance Health
- 428.930
- +11.160+2.67%
Close Nov 6 16:00 ET
- 428.930
- 0.0000.00%
Post 20:01 ET
99.48BMarket Cap15.61P/E (TTM)
432.480High408.070Low3.17MVolume412.880Open417.770Pre Close1.35BTurnover1.37%Turnover Ratio17.01P/E (Static)231.92MShares565.55852wk High2.27P/B99.25BFloat Cap397.98052wk Low6.37Dividend TTM231.40MShs Float565.558Historical High1.49%Div YieldTTM5.84%Amplitude16.496Historical Low425.768Avg Price1Lot Size
Elevance Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.36%45.15B | -0.06%43.65B | 0.96%42.58B | 9.42%171.34B | 6.81%42.65B | 7.29%42.85B | 13.05%43.67B | 10.70%42.17B | 12.95%156.6B | 9.15%39.93B |
| Total premiums earned | 4.40%36.81B | -3.21%35.42B | -0.48%35.7B | 7.22%142.85B | 4.43%35.14B | 4.56%35.26B | 10.62%36.59B | 9.40%35.87B | 13.51%133.23B | 9.35%33.65B |
| -Net premiums written | ---- | ---- | ---- | 7.22%142.85B | ---- | ---- | ---- | ---- | 13.51%133.23B | ---- |
| Net investment income | 11.76%551M | 22.12%508M | 20.16%465M | -9.87%420M | -35.60%-876M | 32.88%493M | 9.19%416M | 7.50%387M | -19.66%466M | -44.84%-646M |
| Net realized gain loss on investments | -0.81%-125M | 29.75%-85M | -42.48%-161M | 51.60%711M | 17.73%1.07B | -117.54%-124M | 47.62%-121M | 25.17%-113M | -57.97%469M | -10.01%908M |
| Fee revenue and other income | 9.54%7.91B | 15.01%7.81B | 9.07%6.58B | 21.95%27.36B | 21.51%7.32B | 22.33%7.22B | 25.56%6.79B | 18.21%6.03B | 14.62%22.43B | 14.71%6.02B |
| -Fees and commissions | -1.03%2.02B | 18.04%2.28B | 3.49%2.08B | 6.04%7.9B | 2.02%1.92B | 5.85%2.04B | 4.95%1.93B | 11.56%2.01B | 7.81%7.45B | 9.28%1.88B |
| -Other income expense | 13.71%5.89B | 13.81%5.53B | 11.86%4.5B | 29.87%19.45B | 30.38%5.39B | 30.34%5.18B | 36.18%4.86B | 21.84%4.02B | 18.34%14.98B | 17.36%4.14B |
| Total expenses | 6.26%43.77B | -1.38%40.66B | 0.21%39.64B | 9.82%163.63B | 7.10%41.65B | 8.95%41.2B | 12.93%41.23B | 10.52%39.55B | 14.05%149B | 10.75%38.88B |
| Loss adjustment expense | 7.66%32.95B | -3.27%30.57B | -0.78%30.55B | 6.59%124.33B | 3.77%31.33B | 4.03%30.61B | 9.76%31.6B | 9.05%30.79B | 13.72%116.64B | 9.94%30.2B |
| Depreciation and amortization | -42.45%122M | -26.70%162M | -50.64%116M | 15.38%885M | -12.15%217M | -5.78%212M | 33.13%221M | 82.17%235M | 73.92%767M | 82.96%247M |
| -Amortization | -42.45%122M | -26.70%162M | -50.64%116M | 15.38%885M | -12.15%217M | -5.78%212M | 33.13%221M | 82.17%235M | 73.92%767M | 82.96%247M |
| Non-operating net interest income (expenses) | -15.83%-300M | -7.28%-280M | -5.58%-265M | -21.03%-1.03B | -13.10%-259M | -21.60%-259M | -25.48%-261M | -24.88%-251M | -6.64%-851M | -14.50%-229M |
| -Interest expense-non operating | 15.83%300M | 7.28%280M | 5.58%265M | 21.03%1.03B | 13.10%259M | 21.60%259M | 25.48%261M | 24.88%251M | 6.64%851M | 14.50%229M |
| Special income (charges) | ---39M | --240M | ---- | --0 | --0 | --0 | --0 | ---- | --0 | ---- |
| -Less：Other special charges | --39M | ---240M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -16.99%1.37B | 22.33%2.99B | 12.22%2.94B | 1.51%7.72B | -4.21%1B | -22.24%1.65B | 15.03%2.44B | 13.57%2.62B | -4.94%7.6B | -28.91%1.05B |
| Income tax | 3.11%365M | 17.09%685M | 12.20%690M | 0.70%1.72B | 1.19%170M | -33.08%354M | 19.88%585M | 16.70%615M | -7.26%1.71B | -42.27%168M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -22.46%1.01B | 23.98%2.3B | 12.23%2.25B | 1.75%5.99B | -5.25%831M | -18.65%1.3B | 13.59%1.86B | 12.65%2B | -4.24%5.89B | -25.61%877M |
| Net Income continuous operations | -22.46%1.01B | 23.98%2.3B | 12.23%2.25B | 1.75%5.99B | -5.25%831M | -18.65%1.3B | 13.59%1.86B | 12.65%2B | -4.24%5.89B | -25.61%877M |
| Minority interest income | -172.73%-8M | -66.67%1M | -80.00%3M | 166.67%4M | -308.33%-25M | 320.00%11M | 200.00%3M | 250.00%15M | 33.33%-6M | 200.00%12M |
| Net income attributable to the parent company | -21.18%1.02B | 24.12%2.3B | 12.92%2.25B | 1.58%5.99B | -1.04%856M | -19.59%1.29B | 13.19%1.85B | 11.18%1.99B | -4.29%5.89B | -27.37%865M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -21.18%1.02B | 24.12%2.3B | 12.92%2.25B | 1.58%5.99B | -1.04%856M | -19.59%1.29B | 13.19%1.85B | 11.18%1.99B | -4.29%5.89B | -27.37%865M |
| Basic earnings per share | -20.07%4.38 | 26.56%9.91 | 15.29%9.65 | 3.34%25.38 | -7.91%3.6727 | -18.09%5.48 | 15.15%7.83 | 12.96%8.37 | -2.77%24.56 | -15.20%3.9881 |
| Diluted earnings per share | -20.00%4.36 | 26.44%9.85 | 15.54%9.59 | 3.87%25.22 | -7.63%3.63 | -17.67%5.45 | 15.75%7.79 | 13.39%8.3 | -2.69%24.28 | -15.12%3.93 |
| Dividend per share | 10.14%1.63 | 10.14%1.63 | 10.14%1.63 | 15.63%5.92 | 15.63%1.48 | 15.63%1.48 | 15.63%1.48 | 15.63%1.48 | 13.27%5.12 | 13.27%1.28 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data